vs
Side-by-side financial comparison of Evercore Inc. (EVR) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Evercore Inc.). Evercore Inc. runs the higher net margin — 15.7% vs -13.6%, a 29.3% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (32.4% vs -5.3%). Evercore Inc. produced more free cash flow last quarter ($798.6M vs $96.0M). Over the past eight quarters, Evercore Inc.'s revenue compounded faster (48.9% CAGR vs -3.6%).
Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
EVR vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $204.0M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 24.2% | -9.8% |
| Net Margin | 15.7% | -13.6% |
| Revenue YoY | 32.4% | -5.3% |
| Net Profit YoY | 45.2% | -288.1% |
| EPS (diluted) | $4.80 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.0B | $1.6B | ||
| Q2 25 | $838.0M | $1.6B | ||
| Q1 25 | $699.0M | $1.5B | ||
| Q4 24 | $979.5M | $1.6B | ||
| Q3 24 | $738.4M | $1.6B | ||
| Q2 24 | $693.4M | $1.6B | ||
| Q1 24 | $585.0M | $1.6B |
| Q4 25 | $204.0M | $-205.0M | ||
| Q3 25 | $144.6M | $160.0M | ||
| Q2 25 | $97.2M | $145.0M | ||
| Q1 25 | $146.2M | $87.0M | ||
| Q4 24 | $140.4M | $109.0M | ||
| Q3 24 | $78.4M | $359.0M | ||
| Q2 24 | $73.8M | $195.0M | ||
| Q1 24 | $85.7M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 24.2% | -9.8% | ||
| Q3 25 | 20.8% | 15.2% | ||
| Q2 25 | 18.0% | 14.4% | ||
| Q1 25 | 16.0% | 6.7% | ||
| Q4 24 | 21.8% | 8.1% | ||
| Q3 24 | 16.7% | 13.1% | ||
| Q2 24 | 15.9% | 14.6% | ||
| Q1 24 | 14.8% | 14.5% |
| Q4 25 | 15.7% | -13.6% | ||
| Q3 25 | 13.8% | 10.0% | ||
| Q2 25 | 11.6% | 9.1% | ||
| Q1 25 | 20.9% | 5.8% | ||
| Q4 24 | 14.3% | 6.8% | ||
| Q3 24 | 10.6% | 22.7% | ||
| Q2 24 | 10.6% | 12.1% | ||
| Q1 24 | 14.6% | 12.4% |
| Q4 25 | $4.80 | $-0.78 | ||
| Q3 25 | $3.41 | $0.61 | ||
| Q2 25 | $2.36 | $0.56 | ||
| Q1 25 | $3.48 | $0.33 | ||
| Q4 24 | $3.32 | $0.42 | ||
| Q3 24 | $1.86 | $1.38 | ||
| Q2 24 | $1.81 | $0.75 | ||
| Q1 24 | $2.09 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0B | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $2.0B | $752.0M |
| Total Assets | $5.4B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0B | $574.0M | ||
| Q3 25 | $2.4B | $672.0M | ||
| Q2 25 | $1.7B | $599.0M | ||
| Q1 25 | $1.4B | $547.0M | ||
| Q4 24 | $2.4B | $675.0M | ||
| Q3 24 | $1.8B | $763.0M | ||
| Q2 24 | $1.7B | $704.0M | ||
| Q1 24 | $1.4B | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $2.0B | $752.0M | ||
| Q3 25 | $1.8B | $906.0M | ||
| Q2 25 | $1.7B | $733.0M | ||
| Q1 25 | $1.5B | $542.0M | ||
| Q4 24 | $1.7B | $472.0M | ||
| Q3 24 | $1.6B | $493.0M | ||
| Q2 24 | $1.5B | $144.0M | ||
| Q1 24 | $1.4B | $48.0M |
| Q4 25 | $5.4B | $12.9B | ||
| Q3 25 | $4.4B | $13.6B | ||
| Q2 25 | $3.7B | $13.5B | ||
| Q1 25 | $3.3B | $13.2B | ||
| Q4 24 | $4.2B | $13.1B | ||
| Q3 24 | $3.6B | $12.8B | ||
| Q2 24 | $3.3B | $12.2B | ||
| Q1 24 | $3.0B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $807.5M | $141.0M |
| Free Cash FlowOCF − Capex | $798.6M | $96.0M |
| FCF MarginFCF / Revenue | 61.6% | 6.4% |
| Capex IntensityCapex / Revenue | 0.7% | 3.0% |
| Cash ConversionOCF / Net Profit | 3.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $807.5M | $141.0M | ||
| Q3 25 | $560.9M | $264.0M | ||
| Q2 25 | $437.7M | $220.0M | ||
| Q1 25 | $-549.7M | $75.0M | ||
| Q4 24 | $686.4M | $390.0M | ||
| Q3 24 | $234.5M | $141.0M | ||
| Q2 24 | $348.5M | $332.0M | ||
| Q1 24 | $-281.2M | $76.0M |
| Q4 25 | $798.6M | $96.0M | ||
| Q3 25 | $541.5M | $218.0M | ||
| Q2 25 | $411.7M | $181.0M | ||
| Q1 25 | $-569.3M | $43.0M | ||
| Q4 24 | $673.1M | $335.0M | ||
| Q3 24 | $226.6M | $99.0M | ||
| Q2 24 | $340.7M | $300.0M | ||
| Q1 24 | $-282.3M | $30.0M |
| Q4 25 | 61.6% | 6.4% | ||
| Q3 25 | 51.8% | 13.6% | ||
| Q2 25 | 49.1% | 11.4% | ||
| Q1 25 | -81.4% | 2.8% | ||
| Q4 24 | 68.7% | 21.0% | ||
| Q3 24 | 30.7% | 6.3% | ||
| Q2 24 | 49.1% | 18.7% | ||
| Q1 24 | -48.3% | 1.8% |
| Q4 25 | 0.7% | 3.0% | ||
| Q3 25 | 1.9% | 2.9% | ||
| Q2 25 | 3.1% | 2.4% | ||
| Q1 25 | 2.8% | 2.1% | ||
| Q4 24 | 1.4% | 3.5% | ||
| Q3 24 | 1.1% | 2.7% | ||
| Q2 24 | 1.1% | 2.0% | ||
| Q1 24 | 0.2% | 2.8% |
| Q4 25 | 3.96× | — | ||
| Q3 25 | 3.88× | 1.65× | ||
| Q2 25 | 4.50× | 1.52× | ||
| Q1 25 | -3.76× | 0.86× | ||
| Q4 24 | 4.89× | 3.58× | ||
| Q3 24 | 2.99× | 0.39× | ||
| Q2 24 | 4.72× | 1.70× | ||
| Q1 24 | -3.28× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVR
| Advisory Fees | $1.1B | 87% |
| Commissions And Related Revenue | $66.5M | 5% |
| Underwriting Fees | $49.5M | 4% |
| Other | $29.6M | 2% |
| Investment Management | $23.2M | 2% |
OGN
Segment breakdown not available.
